BIOMAT Database Logo BIOMAT Database Logo

Effect of heparin on the fibrinolytic response to plasminogen activators. 1991

R Fears, and A F Esmail, and H C Greenwood
SmithKline Beecham Pharmaceuticals, Epsom, United Kingdom.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

R Fears, and A F Esmail, and H C Greenwood
THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN.
January 1964, Scandinavian journal of haematology,
R Fears, and A F Esmail, and H C Greenwood
Kinetic studies on the effect of heparin and fibrin on plasminogen activators.
January 1988, The Biochemical journal,
R Fears, and A F Esmail, and H C Greenwood
Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin.
June 1986, Thrombosis research,
R Fears, and A F Esmail, and H C Greenwood
Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
November 1993, Thrombosis and haemostasis,
R Fears, and A F Esmail, and H C Greenwood
Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
July 1986, Biochemistry,
R Fears, and A F Esmail, and H C Greenwood
A miniaturized fibrinolytic assay for plasminogen activators.
October 1991, Thrombosis research,
R Fears, and A F Esmail, and H C Greenwood
Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators.
October 1982, Thrombosis research,
R Fears, and A F Esmail, and H C Greenwood
Effect of heparin on the fibrinolytic system.
January 1966, Surgical forum,
R Fears, and A F Esmail, and H C Greenwood
A quantitative fibrinolytic method for estimating bacterial activators of plasminogen.
February 1962, Biochimica et biophysica acta,
R Fears, and A F Esmail, and H C Greenwood
[Effect of steroids on the biosynthesis of plasminogen activators].
January 1986, Folia haematologica (Leipzig, Germany : 1928),
Copied contents to your clipboard!